Voltage-sensor mutations in channelopathies of skeletal muscle

Stephen C Cannon1

  • 1Department of Neurology and Program in Neuroscience, 5323 Harry Hines Blvd, UT Southwestern Medical Center, Dallas, TX 75390-8813, USA. steve.cannon@utsouthwestern.edu

The Journal of Physiology
|February 17, 2010
PubMed

Insights

Mutations in skeletal muscle ion channels cause channelopathies like myotonia and periodic paralysis. A newly identified "gating pore" pathway may explain weakness in hypokalaemic periodic paralysis (HypoPP) attacks.

Area of Science:

  • Molecular biology
  • Neuroscience
  • Genetics

Background:

  • Skeletal muscle channelopathies result from voltage-gated ion channel mutations.
  • These mutations cause myotonia or periodic paralysis due to altered ion channel function.
  • The cause of depolarization-induced weakness in hypokalaemic periodic paralysis (HypoPP) remained unclear.

Purpose of the Study:

  • To investigate the mechanism underlying depolarization-induced weakness in HypoPP.
  • To explore the role of the "gating pore" pathway in HypoPP.

Main Methods:

  • Analysis of mutations in voltage-gated sodium and calcium channels.
  • Expression studies of mutant ion channels.
  • Electrophysiological characterization of ion channel function.

Main Results:

  • Mutant ion channels can exhibit loss-of-function or gain-of-function defects.
  • Most HypoPP mutations occur in S4 voltage sensors.
  • These mutations facilitate an alternative ion conduction pathway, the gating pore.

Conclusions:

  • The gating pore pathway provides a mechanistic link between mutations and aberrant depolarization during HypoPP attacks.
  • This finding clarifies a long-standing enigma in the pathophysiology of periodic paralysis.
  • Understanding the gating pore is crucial for developing targeted therapies for channelopathies.

Related Concept Videos

Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Generation of Action Potential in Skeletal Muscles01:24

Generation of Action Potential in Skeletal Muscles

Every cell in the body maintains a membrane potential due to an uneven distribution of positive and negative charges across its plasma membrane. The membrane potential is measured in millivolts and quantifies the difference in charge across the membrane.
Like neurons, muscle cells are also regarded as excitable due to their capacity to change in response to stimuli, primarily due to voltage-gated ion channels embedded in their plasma membranes, which get activated by alterations in the cell's...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Mutations01:39

Mutations

Overview